Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 19 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan

Article in eNeurologicalSci (October 2021)

Neurotoxicology Clinical Approach and Causal Inference

Article in Neurologic Clinics (November 2020)

Clinical duration of action of different botulinum toxin types in humans

Article in Toxicon (March 2020)